|
1
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Warnakulasuriya S: Living with oral
cancer: Epidemiology with particular reference to prevalence and
life-style changes that influence survival. Oral Oncol. 46:407–410.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perez-Ordoñez B, Beauchemin M and Jordan
RC: Molecular biology of squamous cell carcinoma of the head and
neck. J Clin Pathol. 59:445–453. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pérez-Sayáns M, Somoza-Martin JM,
Barros-Angueira F, Reboiras-Lopez MD, Gándara Rey JM and
Garcia-García A: Genetic and molecular alterations associated with
oral squamous cell cancer (Review). Oncol Rep. 22:1277–1282. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Todd R, Hinds PW, Munger K, Rustgi AK,
Opitz OG, Suliman Y and Wong DT: Cell cycle dysregulation in oral
cancer. Crit Rev Oral Biol Med. 13:51–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patel V, Jakus J, Harris CM, Ensley JF,
Robbins KC and Yeudall WA: Altered expression and activity of G1/S
cyclins and cyclin-dependent kinases characterize squamous cell
carcinomas of the head and neck. Int J Cancer. 73:551–555. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sherr CJ and Roberts JM: Inhibitors of
mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Harper JW, Adami GR, Wei N, Keyomarsi K
and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent
inhibitor of G1 cyclin-dependent kinases. Cell. 75:805–816. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pérez-Sayáns M, Suárez-Peñaranda JM,
Gayoso-Diz P, Barros-Angueira F, Gándara-Rey JM and García-García
A: p16 (INK4a)/CDKN2 expression and its relationship with oral
squamous cell carcinoma is our current knowledge enough? Cancer
Lett. 306:134–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pérez-Sayáns M, Suárez-Peñaranda JM,
Gayoso-Diz P, et al: The role of p21Waf1/CIP1 as a Cip/Kip type
cell-cycle regulator in oral squamous cell carcinoma (Review). Med
Oral Patol Oral Cir Bucal. 18:e219–e225. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toyoshima H and Hunter T: p27, a novel
inhibitor of G1 cyclin-Cdk protein kinase activity, is related to
p21. Cell. 78:67–74. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Migita T, Oda Y, Naito S and Tsuneyoshi M:
Low expression of p27 (Kip1) is associated with tumor size and poor
prognosis in patients with renal cell carcinoma. Cancer.
94:973–979. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhuang Y, Yin HT, Yin XL, Wang J and Zhang
DP: High p27 expression is associated with a better prognosis in
east Asian non-small cell lung cancer patients. Clin Chim Acta.
412:2228–2231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nozoe T, Oyama T, Takenoyama M, Hanagiri
T, Sugio K and Yasumoto K: Significance of immunohistochemical
expression of p27 and involucrin as the marker of cellular
differentiation of squamous cell carcinoma of the esophagus.
Oncology. 71:402–410. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kouvaraki M, Gorgoulis VG, Rassidakis GZ,
Liodis P, Markopoulos C, Gogas J and Kittas C: High expression
levels of p27 correlate with lymph node status in a subset of
advanced invasive breast carcinomas: Relation to E-cadherin
alterations, proliferative activity and ploidy of the tumors.
Cancer. 94:2454–2465. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kudo Y, Kitajima S, Ogawa I, Miyauchi M
and Takata T: Down-regulation of Cdk inhibitor p27 in oral squamous
cell carcinoma. Oral Oncol. 41:105–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kudo Y, Takata T, Yasui W, Ogawa I,
Miyauchi M, Takekoshi T, Tahara E and Nikai H: Reduced expression
of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of
malignant behavior in oral squamous cell carcinoma. Cancer.
83:2447–2455. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fujieda S, Inuzuka M, Tanaka N, Sunaga H,
Fan GK, Ito T, Sugimoto C, Tsuzuki H and Saito H: Expression of p27
is associated with Bax expression and spontaneous apoptosis in oral
and oropharyngeal carcinoma. Int J Cancer. 84:315–320. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jordan RC, Bradley G and Slingerland J:
Reduced levels of the cell-cycle inhibitor p27Kip1 in epithelial
dysplasia and carcinoma of the oral cavity. Am J Pathol.
152:585–590. 1998.PubMed/NCBI
|
|
20
|
Ito R, Yasui W, Ogawa Y, Toyosawa S,
Tahara E and Ijuhin N: Reduced expression of cyclin-dependent
kinase inhibitor p27 (Kip1) in oral malignant tumors. Pathobiology.
67:169–173. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mineta H, Miura K, Suzuki I, Takebayashi
S, Amano H, Araki K, Harada H, Ichimura K, Wennerberg JP and Dictor
MR: Low p27 expression correlates with poor prognosis for patients
with oral tongue squamous cell carcinoma. Cancer. 85:1011–1017.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schoelch ML, Regezi JA, Dekker NP, Ng IO,
McMillan A, Ziober BL, Le QT, Silverman S and Fu KK: Cell cycle
proteins and the development of oral squamous cell carcinoma. Oral
Oncol. 35:333–342. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Saito T, Nakajima T and Mogi K:
Immunohistochemical analysis of cell cycle-associated proteins p16,
pRb, p53, p27 and Ki-67 in oral cancer and precancer with special
reference to verrucous carcinomas. J Oral Pathol Med. 28:226–232.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Venkatesan TK, Kuropkat C, Caldarelli DD,
Panje WR, Hutchinson JC Jr, Chen S and Coon JS: Prognostic
significance of p27 expression in carcinoma of the oral cavity and
oropharynx. Laryngoscope. 109:1329–1333. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kudo Y, Takata T, Ogawa I, Zhao M, Sato S,
Takekoshi T, Miyauchi M and Nikai H: Reduced expression of p27
(Kip1) correlates with an early stage of cancer invasion in oral
squamous cell carcinoma. Cancer Lett. 151:217–222. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kapranos N, Stathopoulos GP, Manolopoulos
L, Kokka E, Papadimitriou C, Bibas A, Yiotakis J and Adamopoulos G:
P53, p21 and p27 protein expression in head and neck cancer and
their prognostic value. Anticancer Res. 21:521–528. 2001.PubMed/NCBI
|
|
27
|
Kudo Y, Kitajima S, Sato S, Miyauchi M,
Ogawa I and Takata T: High expression of S-phase kinase-interacting
protein 2, human F-box protein, correlates with poor prognosis in
oral squamous cell carcinomas. Cancer Res. 61:7044–7047.
2001.PubMed/NCBI
|
|
28
|
Harada K, Supriatno, Yoshida H and Sato M:
Low p27Kip1 expression is associated with poor prognosis in oral
squamous cell carcinoma. Anticancer Res. 22:2985–2989.
2002.PubMed/NCBI
|
|
29
|
Kuo MY, Hsu HY, Kok SH, Kuo RC, Yang H,
Hahn LJ and Chiang CP: Prognostic role of p27 (Kip1) expression in
oral squamous cell carcinoma in Taiwan. Oral Oncol. 38:172–178.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shintani S, Mihara M, Nakahara Y, Kiyota
A, Ueyama Y, Matsumura T and Wong DT: Expression of cell cycle
control proteins in normal epithelium, premalignant and malignant
lesions of oral cavity. Oral Oncol. 38:235–243. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kuropkat C, Venkatesan TK, Caldarelli DD,
Panje WR, Hutchinson J, Preisler HD, Coon JS and Werner JA:
Abnormalities of molecular regulators of proliferation and
apoptosis in carcinoma of the oral cavity and oropharynx. Auris
Nasus Larynx. 29:165–174. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi HR, Tucker SA, Huang Z, Gillenwater
AM, Luna MA, Batsakis JG and El-Naggar AK: Differential expressions
of cyclin-dependent kinase inhibitors (p27 and p21) and their
relation to p53 and Ki-67 in oral squamous tumorigenesis. Int J
Oncol. 22:409–414. 2003.PubMed/NCBI
|
|
33
|
Shintani S, Li C, Mihara M, Hino S,
Nakashiro K and Hamakawa H: Skp2 and Jab1 expression are associated
with inverse expression of p27 (KIP1) and poor prognosis in oral
squamous cell carcinomas. Oncology. 65:355–362. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Harada K, Supriatno, Yamamoto S, Kawaguchi
S, Yoshida H and Sato M: Cepharanthine exerts antitumor activity on
oral squamous cell carcinoma cell lines by induction of p27Kip1.
Anticancer Res. 23:1441–1448. 2003.PubMed/NCBI
|
|
35
|
Kitajima S, Kudo Y, Ogawa I, Bashir T,
Kitagawa M, Miyauchi M, Pagano M and Takata T: Role of Cks1
overexpression in oral squamous cell carcinomas: Cooperation with
Skp2 in promoting p27 degradation. Am J Pathol. 165:2147–2155.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rodolico V, Barresi E, Di Lorenzo R,
Leonardi V, Napoli P, Rappa F and Di Bernardo C: Lymph node
metastasis in lower lip squamous cell carcinoma in relation to
tumour size, histologic variables and p27Kip1 protein expression.
Oral Oncol. 40:92–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rodolico V, Aragona F, Cabibi D, Di
Bernardo C, Di Lorenzo R, Gebbia N, Gulotta G, Leonardi V and
Ajello F: Overexpression of cyclin D1 and interaction between
p27Kip1 and tumour thickness predict lymph node metastases
occurrence in lower lip squamous cell carcinoma. Oral Oncol.
41:268–275. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fillies T, Woltering M, Brandt B, Van
Diest JP, Werkmeister R, Joos Uz and Buerger H: Cell cycle
regulating proteins p21 and p27 in prognosis of oral squamous cell
carcinomas. Oncol Rep. 17:355–359. 2007.PubMed/NCBI
|
|
39
|
Queiroz AB, Focchi G, Dobo C, Gomes TS,
Ribeiro DA and Oshima CT: Expression of p27, p21 (WAF/Cip1) and p16
(INK4a) in normal oral epithelium, oral squamous papilloma and oral
squamous cell carcinoma. Anticancer Res. 30:2799–2803.
2010.PubMed/NCBI
|
|
40
|
Martín-Ezquerra G, Salgado R, Toll A, Baró
T, Mojal S, Yébenes M, Garcia-Muret MP, Solé F, Quitllet FA,
Espinet B and Pujol RM: CDC28 protein kinase regulatory subunit 1B
(CKS1B) expression and genetic status analysis in oral squamous
cell carcinoma. Histol Histopathol. 26:71–77. 2011.PubMed/NCBI
|
|
41
|
Gao L, Huang S, Ren W, Zhao L, Li J, Zhi
K, Zhang Y, Qi H and Huang C: Jun activation domain-binding protein
1 expression in oral squamous cell carcinomas inversely correlates
with the cell cycle inhibitor p27. Med Oncol. 29:2499–2504. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Monteiro LS, Diniz-Freitas M,
Garcia-Caballero T, Warnakulasuriya S, Forteza J and Fraga M:
Combined cytoplasmic and membranous EGFR and p53 overexpression is
a poor prognostic marker in early stage oral squamous cell
carcinoma. J Oral Pathol Med. 41:559–567. 2012.PubMed/NCBI
|
|
43
|
Perisanidis C, Perisanidis B, Wrba F,
Brandstetter A, El Gazzar S, Papadogeorgakis N, Seemann R, Ewers R,
Kyzas PA and Filipits M: Evaluation of immunohistochemical
expression of p53, p21, p27, cyclin D1 and Ki67 in oral and
oropharyngeal squamous cell carcinoma. J Oral Pathol Med. 41:40–46.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Canzonieri V, Barzan L, Franchin G,
Vaccher E, Talamini R, Sulfaro S and Baldassarre G: Alteration of
G1/S transition regulators influences recurrences in head and neck
squamous carcinomas. J Cell Physiol. 227:233–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang M, Li J, Wang L, Tian Z, Zhang P, Xu
Q, Zhang C, Wei F and Chen W: Prognostic significance of p21, p27
and survivin protein expression in patients with oral squamous cell
carcinoma. Oncol Lett. 6:381–386. 2013.PubMed/NCBI
|
|
46
|
Shintani S, Li C, Mihara M, Hino S,
Nakashiro K and Hamakawa H: Skp2 and Jab1 expression are associated
with inverse expression of p27 (KIP1) and poor prognosis in oral
squamous cell carcinomas. Oncology. 65:355–362. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fan GK, Chen J, Ping F and Geng Y:
Immunohistochemical analysis of P57 (kip2), p53 and hsp60
expressions in premalignant and malignant oral tissues. Oral Oncol.
42:147–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pignataro L, Sambataro G, Pagani D and
Pruneri G: Clinico-prognostic value of D-type cyclins and p27 in
laryngeal cancer patients: A review. Acta Otorhinolaryngol Ital.
25:75–85. 2005.PubMed/NCBI
|
